| Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection M Zhao, E Bozzato, N Joudiou, S Ghiassinejad, F Danhier, B Gallez, ... Journal of Controlled Release 309, 72-81, 2019 | 103 | 2019 |
| Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment C Bastiancich, E Bozzato, U Luyten, F Danhier, G Bastiat, V Préat International journal of pharmaceutics 559, 220-227, 2019 | 56 | 2019 |
| Combinational drug-loaded lipid nanocapsules for the treatment of cancer N Tsakiris, M Papavasileiou, E Bozzato, A Lopes, AM Vigneron, V Préat International journal of pharmaceutics 569, 118588, 2019 | 33 | 2019 |
| Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review C Bastiancich, E Bozzato, I Henley, B Newland Journal of Controlled Release, 2021 | 31 | 2021 |
| Nanomedicine: A Useful Tool against Glioma Stem Cells E Bozzato, C Bastiancich, V Préat Cancers 13 (1), 9, 2021 | 22 | 2021 |
| Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression” M Bausart, E Bozzato, N Joudiou, X Koutsoumpou, B Manshian, V Préat, ... Cancers 15 (6), 1919, 2023 | 8 | 2023 |
| Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells E Bozzato, N Tsakiris, A Paquot, GG Muccioli, C Bastiancich, V Préat International Journal of Pharmaceutics 628, 122341, 2022 | 5 | 2022 |
